Parkinson's Disease: A Narrative Review on Potential Molecular Mechanisms of Sleep Disturbances, REM Behavior Disorder, and Melatonin
Summary:
The paper discusses the molecular mechanisms of sleep disturbances, REM Behavior Disorder, and the role of melatonin in Parkinson's disease.
Categories
- Dementia: The paper mentions dementia in the context of Parkinson's disease, discussing how Lewy pathology, which includes the formation of Lewy bodies, is associated with dementia in Parkinson's disease.
- Sleep and insomnia: The paper extensively discusses sleep disturbances, including insomnia, in patients with Parkinson's disease, exploring the potential molecular mechanisms and the role of melatonin in these disturbances.
- Cognitive function and memory: The paper discusses the impact of Parkinson's disease on cognitive function, particularly in relation to sleep disturbances and the role of various neurotransmitter systems.
- Aging: The paper discusses Parkinson's disease, a neurodegenerative disorder that primarily affects the elderly population, and its impact on sleep and cognitive function.
- Mood regulation: The paper discusses the role of melatonin, a hormone that significantly modulates mood state, in the context of sleep disturbances in Parkinson's disease.
- Hormone regulation: The paper discusses the role of melatonin, a hormone secreted by the pineal gland, in the regulation of sleep and mood in Parkinson's disease.
Author(s)
MA Samizadeh, H Fallah, M Toomarisahzabi, F Rezaei
Publication Year:
2023
Number of Citations:
0
Related Publications
Dementia
- Photoreception for circadian, neuroendocrine, and neurobehavioral regulation
- New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
- Sleep and circadian rhythms in Parkinson's disease and preclinical models
- Chronobioengineering indoor lighting to enhance facilities for ageing and Alzheimer's disorder
Sleep and insomnia
- The two‐process model of sleep regulation: a reappraisal
- Strange vision: ganglion cells as circadian photoreceptors
- Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function
- Functional and morphological differences among intrinsically photosensitive retinal ganglion cells
Cognitive function and memory
- Phototransduction by retinal ganglion cells that set the circadian clock
- The two‐process model of sleep regulation: a reappraisal
- Strange vision: ganglion cells as circadian photoreceptors
- Information processing in the primate retina: circuitry and coding
Aging
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease
- Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead
Mood regulation
- Effects of artificial dawn and morning blue light on daytime cognitive performance, well-being, cortisol and melatonin levels
- Nocturnal light exposure impairs affective responses in a wavelength-dependent manner
- The role of the circadian clock in animal models of mood disorders.
- Signalling by melanopsin (OPN4) expressing photosensitive retinal ganglion cells
Hormone regulation
- Phototransduction by retinal ganglion cells that set the circadian clock
- The impact of light from computer monitors on melatonin levels in college students
- Circadian rhythms–from genes to physiology and disease
- Effects of artificial dawn and morning blue light on daytime cognitive performance, well-being, cortisol and melatonin levels